Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10640511 Hepatitis B antiviral agents

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

May 5, 2020

0

Patent Application Number

162202670

Date Filed

December 14, 2018

0

Patent Citations

US Patent 10189846 Hepatitis B antiviral agents

US Patent 10428070 Hepatitis B antiviral agents

US Patent 10179131 Hepatitis B antiviral agents

US Patent 10253030 Crystal form, preparation method and intermediate of dihydropyrido ring compound

0

Patent Citations Received

0

US Patent 11891393 Functionalized heterocycles as antiviral agents

0

US Patent 12011425 Hepatitis B antiviral agents

0

US Patent 11472808 Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents

US Patent 11596611 Hepatitis B antiviral agents

0

US Patent 11760755 Hepatitis B antiviral agents

US Patent 11802125 Functionalized heterocyclic compounds as antiviral agents

US Patent 11377450 Functionalized heterocycles as antiviral agents

Patent Primary Examiner

Jeffrey H Murray

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10640511 Hepatitis B antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool